Category: RadiosurgerySyndicate content

Revenue surge helps Accuray narrow Q3 losses, update full-year outlook

May 2, 2014 by Arezu Sarvestani

California medtech maker Accuray boosts its full-year revenue outlook after posting Q3 2014 sales nearly 40% higher than last year.

Revenue surge helps Accuray narrow Q3 losses, update full-year outlook

Radiosurgery systems maker Accuray (NSDQ:ARAY) sees continued momentum on the horizon as a boost in Q3 sales prompts an updated, increased full-year outlook.

Patent battle takes a chunk out of Varian's bottom line

April 30, 2014 by Arezu Sarvestani

California-based Varian Medical System shaves 16¢ off of its per-share earnings for charges related to a patent infringement settlement with the University of Pittsburgh.

Patent battle takes 15% off Varian's bottom line

Radiosurgery devices maker Varian Medical (NYSE:VAR) posted a tough quarter, with sales up a modest 1.3% and earnings sucked up by legal charges in its 2nd quarter.

Varian settles patent beef with Pitt for $35M

April 11, 2014 by Brad Perriello

Varian Medical Systems agrees to pay about $35 million to settle a patent infringement lawsuit brought by the University of Pittsburgh, after a federal appeals court overturns a portion of its $100 million loss to Pitt.

Varian settles patent beef with Pitt for $35M

Varian Medical (NYSE:VAR) said it settled its patent infringement beef with the University of Pittsburgh for $35 million, after a federal appeals court overturned a portion of the $100 million award Pitt won in 2012.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cancer: RefleXion Medical raises $11.6M to 'make radiotherapy personal'

April 4, 2014 by Arezu Sarvestani

RefleXion Medical secures an $11.6 million Series A funding round in support of its cancer-targeting bio-guided radiation therapy system.

RefleXion Medical lands $11.6M Series A for radiation therapy system

California-based medtech group RefleXion Medical touted an $11.6 million Series A fundraising round, hoping to use the new funds to expand research & development efforts for its guided radiation therapy technology.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Halt Medical raises $92.8M ahead of U.S. launch of uterine fibroid treatment

April 3, 2014 by Arezu Sarvestani

Halt Medical has big plans for its Acessa System for treating uterine fibroids, having raised nearly $93 million in efforts to restructure debt and fund its commercial efforts.

Halt Medical raises $92.8M ahead of commercial launch of uterine fibroid treatment

California women's health company Halt Medical is raising capital ahead of a major commercial bid for its Acessa radiofrequency-based uterine fibroid treatment.

AMIC looks to down-classify brachytherapy's FDA status

February 24, 2014 by Arezu Sarvestani

Advanced Medical Isotope Corp. considers pursuing regulatory down-classification for its brachytherapy cancer product.

AMIC aims to shift brachytherapy to lower-risk FDA status

Washington-based Advanced Medical Isotope Corp. is evaluating its options for U.S. market approval of its proprietary brachytherapy cancer product, the company announced.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Accuray notches win in trade secrets row with former supplier

February 11, 2014 by Arezu Sarvestani

Radiosurgery systems maker Accuray lands summary judgment in trade secrets lawsuit filed by former supplier Rotary Systems.

Accuray notches win in trade secrets row with former supplier

California medtech maker Accuray (NSDQ:ARAY) tallied a win in a trade secrets lawsuit filed by a former supplier, announcing that a Minnesota court awarded summary judgment against Rotary Systems.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp